Immunotherapy in Kidney Cancer
0 Ansichten
• 06/26/23
0
0
Einbetten
administrator
Abonnenten
Thomas Hutson, DO, PharmD, FACP; James J. Hsieh, MD, PhD; and Martin H. Voss, MD, explain the clinical rationale for immunotherapeutic approaches in the treatment of renal cell carcinoma and the current role for immunotherapy agents.
Zeig mehr
Facebook Kommentare
SORT BY-
Beste Kommentare
-
Neueste Kommentare